Revvity (RVTY): analysis and statistics
Return, volatility, Sharpe ratio and risk for Revvity, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $113.51 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | -2.38% |
| Total return over period | -6.93% |
| Annualized volatility | 35.61% |
| Sharpe ratio | -0.17 |
| Sortino ratio | -0.24 |
| Max drawdown | -35.30% |
| CVaR 95% (avg. loss, worst 5% of days) | -5.01% |
| Correlation with the S&P 500 | 0.45 |
| Period range | $81.47 – $127.06 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Revvity (RVTY) has posted an annualized return of -2.38% with annual volatility of 35.61%, a negative Sharpe ratio: over this period it did not beat the risk-free Treasury rate. Its worst stretch (max drawdown from a peak) was -35.30%. Its correlation with the S&P 500 is 0.45, which means it moves moderately in step with the index.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how RVTY would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with RVTY →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio